Prescription Drugs - D-A-CH

D-A-CH

In the year 2024, the Prescription Drugs market in the D-A-CH region is projected to reach a revenue of US$78.86bn.
This market is expected to experience an annual growth rate (CAGR 2024-2029) of 3.91%, resulting in a market volume of US$95.53bn by the year 2029.
When compared globally, it is worth noting that United States is expected to generate the highest revenue in the Prescription Drugs market, amounting to US$358.90bn in the year 2024.
In terms of per person revenues, the Prescription Drugs market is estimated to generate US$0.78k in the D-A-CH region in 2024.
This figure provides an indication of the revenue generated per individual in relation to the total population.
In Germany, there is a growing trend towards the use of generic prescription drugs, driven by cost-conscious consumers and a push for healthcare cost containment.

Key regions: Japan, China, Europe, Australia, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Prescription Drugs (Pharmacies) market in D-A-CH is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the positive trajectory of this market. Customer preferences play a crucial role in shaping the Prescription Drugs (Pharmacies) market in D-A-CH. Customers in this region prioritize convenience and accessibility when it comes to purchasing prescription drugs. As a result, there is a growing demand for online pharmacies and home delivery services. This shift in customer preferences has led to the emergence of new players in the market, offering innovative solutions to meet the evolving needs of customers. In terms of trends, the Prescription Drugs (Pharmacies) market in D-A-CH is witnessing a rise in the use of digital technologies. Online platforms and mobile applications are becoming increasingly popular for ordering prescription drugs, managing prescriptions, and accessing healthcare information. This trend is driven by the convenience and efficiency that digital solutions offer, as well as the growing adoption of telemedicine services in the region. As a result, traditional brick-and-mortar pharmacies are adapting their business models to incorporate digital channels, creating a more seamless and integrated customer experience. Local special circumstances also contribute to the development of the Prescription Drugs (Pharmacies) market in D-A-CH. Germany, Switzerland, and Austria have well-established healthcare systems with a strong emphasis on patient-centered care. This focus on quality and patient satisfaction drives the demand for personalized pharmacy services, such as medication counseling, dosage optimization, and medication therapy management. Pharmacies in the region are investing in professional services and expanding their offerings beyond prescription dispensing to meet these needs. Underlying macroeconomic factors further support the growth of the Prescription Drugs (Pharmacies) market in D-A-CH. The aging population in the region, coupled with the increasing prevalence of chronic diseases, creates a higher demand for prescription drugs. Additionally, favorable government regulations and policies promote competition and innovation in the pharmaceutical industry, driving market growth. The strong economy and high disposable income levels in D-A-CH countries also contribute to the affordability and accessibility of prescription drugs, further fueling market expansion. In conclusion, the Prescription Drugs (Pharmacies) market in D-A-CH is experiencing positive growth and development driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The focus on convenience, digitalization, personalized services, and quality healthcare drives the demand for prescription drugs and shapes the evolving landscape of the market in this region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.